Employers Face Dilemmas Over Coverage of Weight-Loss Drugs Amid Soaring Costs

As the demand for GLP-1 weight-loss drugs like Wegovy and Zepbound increases, employers grapple with insurance coverage decisions, balancing employee health benefits against significant financial implications.